Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Qi-Xuan Xu, Liang Guo, Yuan Li, Zhao-Wei Wang, Po Hu, Guang-Ming Yang & Yang Pan. (2023) In silico screening-based discovery of benzamide derivatives as inhibitors of Rho-associated kinase-1 (ROCK1). Journal of Biomolecular Structure and Dynamics 0:0, pages 1-18.
Read now
Read now
Chen Cheng, Salman Jabri, Brandon M Taoka & Christopher J Sinz. (2020) Small molecule glucagon receptor antagonists: an updated patent review (2015–2019). Expert Opinion on Therapeutic Patents 30:7, pages 509-526.
Read now
Read now
André J. Scheen, Nicolas Paquot & Pierre J. Lefèbvre. (2017) Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes. Expert Opinion on Investigational Drugs 26:12, pages 1373-1389.
Read now
Read now
Kevin J Filipski. (2015) Small molecule glucagon receptor antagonists: a patent review (2011 – 2014). Expert Opinion on Therapeutic Patents 25:7, pages 819-830.
Read now
Read now
Articles from other publishers (21)
Thomas Pixner, Nathalie Stummer, Anna Maria Schneider, Andreas Lukas, Karin Gramlinger, Valérie Julian, David Thivel, Katharina Mörwald, Harald Mangge, Christopher Dalus, Elmar Aigner, Dieter Furthner, Daniel Weghuber & Katharina Maruszczak. (2023) The relationship between glucose and the liver-alpha cell axis – A systematic review. Frontiers in Endocrinology 13.
Crossref
Crossref
Zhihai Ke & Ying-Yeung Yeung. 2022. Comprehensive Heterocyclic Chemistry IV. Comprehensive Heterocyclic Chemistry IV
412
449
.
Jane Rhyu & Run Yu. (2021) Newly discovered endocrine functions of the liver. World Journal of Hepatology 13:11, pages 1611-1628.
Crossref
Crossref
Pushyaraga P. Venugopal, Bratin K. Das, E. Soorya & Debashree Chakraborty. (2019) Effect of hydrophobic and hydrogen bonding interactions on the potency of ß‐alanine analogs of G‐protein coupled glucagon receptor inhibitors. Proteins: Structure, Function, and Bioinformatics 88:2, pages 327-344.
Crossref
Crossref
Lise Bankir, Nadine Bouby, Robert C. Speth, Gilberto Velho & Gilles Crambert. (2018) Glucagon revisited: Coordinated actions on the liver and kidney. Diabetes Research and Clinical Practice 146, pages 119-129.
Crossref
Crossref
Lise Bankir, Antonio Barbato, Ornella Russo, Gilles Crambert, Roberto Iacone, Nadine Bouby, Ludovica Perna & Pasquale Strazzullo. (2018) Renal potassium handling in carriers of the Gly40Ser mutation of the glucagon receptor suggests a role for glucagon in potassium homeostasis. Physiological Reports 6:8, pages e13661.
Crossref
Crossref
Fan Wu, Gaojie Song, Chris de Graaf & Raymond C. Stevens. (2017) Structure and Function of Peptide-Binding G Protein-Coupled Receptors. Journal of Molecular Biology 429:17, pages 2726-2745.
Crossref
Crossref
Lise Bankir, Nadine Bouby, Bertrand Blondeau & Gilles Crambert. (2016) Glucagon actions on the kidney revisited: possible role in potassium homeostasis. American Journal of Physiology-Renal Physiology 311:2, pages F469-F486.
Crossref
Crossref
Shuangjie Shu, Xiaoqing Cai, Jia Li, Yang Feng, Antao Dai, Jiang Wang, Dehua Yang, Ming-Wei Wang & Hong Liu. (2016) Design, synthesis, structure–activity relationships, and docking studies of pyrazole-containing derivatives as a novel series of potent glucagon receptor antagonists. Bioorganic & Medicinal Chemistry 24:12, pages 2852-2863.
Crossref
Crossref
Songnian Lin, Fengqi Zhang, Guoqiang Jiang, Sajjad A. Qureshi, Xiaodong Yang, Gary G. Chicchi, Laurie Tota, Alka Bansal, Edward Brady, Maria Trujillo, Gino Salituro, Corey Miller, James R. Tata, Bei B. Zhang & Emma R. Parmee. (2015) A novel series of indazole-/indole-based glucagon receptor antagonists. Bioorganic & Medicinal Chemistry Letters 25:19, pages 4143-4147.
Crossref
Crossref
Matthew F. Sammons & Esther C.Y. Lee. (2015) Recent progress in the development of small-molecule glucagon receptor antagonists. Bioorganic & Medicinal Chemistry Letters 25:19, pages 4057-4064.
Crossref
Crossref
Cathryn Weston, Jing Lu, Naichang Li, Kerry Barkan, Gareth O. Richards, David J. Roberts, Timothy M. Skerry, David Poyner, Meenakshi Pardamwar, Christopher A. Reynolds, Simon J. Dowell, Gary B. Willars & Graham Ladds. (2015) Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2). Journal of Biological Chemistry 290:38, pages 23009-23022.
Crossref
Crossref
Clifford J. Bailey. 2015. International Textbook of Diabetes Mellitus. International Textbook of Diabetes Mellitus
709
725
.
Yanyan Li, Séverine Zirah & Sylvie RebuffatYanyan Li, Séverine Zirah & Sylvie Rebuffat. 2015. Lasso Peptides. Lasso Peptides
37
79
.
Duane DeMong, Xing Dai, Joyce Hwa, Michael Miller, Sue-Ing Lin, Ling Kang, Andrew Stamford, William Greenlee, Wensheng Yu, Michael Wong, Brian Lavey, Joseph Kozlowski, Guowei Zhou, De-Yi Yang, Bhuneshwari Patel, Aileen Soriano, Ying Zhai, Christopher Sondey, Hongtao Zhang, Jean Lachowicz, Diane Grotz, Kathleen Cox, Richard Morrison, Teresa Andreani, Yang Cao, Mark Liang, Tao Meng, Paul McNamara, Jesse Wong, Prudence Bradley, Kung-I Feng, Jitendra Belani, Ping Chen, Peng Dai, Jolicia Gauuan, Peishan Lin & He Zhao. (2014)
The Discovery of
N
-((2
H
-Tetrazol-5-yl)methyl)-4-((
R
)-1-((5
r
,8
R
)-8-(
tert
-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): A Potent and Selective Glucagon Receptor Antagonist
. Journal of Medicinal Chemistry 57:6, pages 2601-2610.
Crossref
Crossref
Run Yu. (2014) Pancreatic α-Cell Hyperplasia: Facts and Myths. The Journal of Clinical Endocrinology & Metabolism 99:3, pages 748-756.
Crossref
Crossref
Esther C.Y. Lee, Meihua Tu, Benjamin D. Stevens, Jianwei Bian, Gary Aspnes, Christian Perreault, Matthew F. Sammons, Stephen W. Wright, John Litchfield, Amit S. Kalgutkar, Raman Sharma, Mary T. Didiuk, David C. Ebner, Kevin J. Filipski, Janice Brown, Karen Atkinson, Jeffrey A. Pfefferkorn & Angel Guzman-Perez. (2014) Identification of a novel conformationally constrained glucagon receptor antagonist. Bioorganic & Medicinal Chemistry Letters 24:3, pages 839-844.
Crossref
Crossref
Angel Guzman-Perez, Jeffrey A. Pfefferkorn, Esther C.Y. Lee, Benjamin D. Stevens, Gary E. Aspnes, Jianwei Bian, Mary T. Didiuk, Kevin J. Filipski, Dianna Moore, Christian Perreault, Matthew F. Sammons, Meihua Tu, Janice Brown, Karen Atkinson, John Litchfield, Beijing Tan, Brian Samas, William J. Zavadoski, Christopher T. Salatto & Judith Treadway. (2013) The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical and pharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitus. Bioorganic & Medicinal Chemistry Letters 23:10, pages 3051-3058.
Crossref
Crossref
James Mu, Sajjad A. Qureshi, Edward J. Brady, Eric S. Muise, Mari Rios Candelore, Guoqiang Jiang, Zhihua Li, Margaret S. Wu, Xiaodong Yang, Qing Dallas-Yang, Corey Miller, Yusheng Xiong, Ronald B. Langdon, Emma R. Parmee & Bei B. Zhang. (2012) Anti-Diabetic Efficacy and Impact on Amino Acid Metabolism of GRA1, a Novel Small-Molecule Glucagon Receptor Antagonist. PLoS ONE 7:11, pages e49572.
Crossref
Crossref
Yusheng Xiong, Jian Guo, Mari R. Candelore, Rui Liang, Corey Miller, Qing Dallas-Yang, Guoqiang Jiang, Peggy E. McCann, Sajjad A. Qureshi, Xinchun Tong, Shiyao Sherrie Xu, Jackie Shang, Stella H. Vincent, Laurie M. Tota, Michael J. Wright, Xiaodong Yang, Bei B. Zhang, James R. Tata & Emma R. Parmee. (2012)
Discovery of a Novel Glucagon Receptor Antagonist
N
-[(4-{(1
S
)-1-[3-(3, 5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1
H
-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the Treatment of Type II Diabetes
. Journal of Medicinal Chemistry 55:13, pages 6137-6148.
Crossref
Crossref
Kevin J. Filipski, Jianwei Bian, David C. Ebner, Esther C.Y. Lee, Jian-Cheng Li, Matthew F. Sammons, Stephen W. Wright, Benjamin D. Stevens, Mary T. Didiuk, Meihua Tu, Christian Perreault, Janice Brown, Karen Atkinson, Beijing Tan, Christopher T. Salatto, John Litchfield, Jeffrey A. Pfefferkorn & Angel Guzman-Perez. (2012) A novel series of glucagon receptor antagonists with reduced molecular weight and lipophilicity. Bioorganic & Medicinal Chemistry Letters 22:1, pages 415-420.
Crossref
Crossref